Wilcock Andrew D, Zubizarreta Jose R, Wadhera Rishi K, Yeh Robert W, Zachrison Kori S, Schwamm Lee H, Mehrotra Ateev
Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
JAMA Cardiol. 2024 Oct 1;9(10):914-920. doi: 10.1001/jamacardio.2024.2031.
The incidence of hospital encounters for acute myocardial infarction (AMI) decreased sharply early in the COVID-19 pandemic and has not returned to prepandemic levels. There has been an ongoing debate about what mechanism may underlie this decline, including patients avoiding the hospital for treatment, excess mortality from COVID-19 among patients who would otherwise have had an AMI, a reduction in the incidence or severity of AMIs due to pandemic-related changes in behavior, or a preexisting temporal trend of lower AMI incidence.
To describe drivers of changing incidence in AMI hospital encounters during the COVID-19 pandemic.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used traditional Medicare claims from all patients enrolled in traditional Medicare from January 2016 to June 2023 (total of 2.85 billion patient-months) to calculate the rate of AMI hospital encounters (emergency department visits, observation stays, or inpatient admissions) per capita at all short-term acute care and critical access hospitals in the United States overall and by patient characteristics. Observed rates were compared with expected rates that accounted for shifts in population characteristics and the prepandemic temporal trend (as estimated over 2016-2019). Data were analyzed in November 2023.
Hospital encounters for AMI.
On average, the study sample included 31 623 928 patients each month from January 2016 through June 2023, for a total of 2 846 153 487 patient-months during the 90-month study period. In June 2023, there were 0.044 AMI hospital encounters per 100 patients, which was 20% lower than in June 2019 (0.055 encounters per 100 patients). Early in the pandemic, AMI rates moved inversely with COVID-19 death rates and tracked patterns seen for other painful acute conditions, such as nephrolithiasis, suggesting these changes were associated with care avoidance. Changes in patient characteristics driven by excess deaths during the pandemic explained little of the decline. Later in the pandemic, the decline may be explained by the long-standing downward trend in AMI incidence; by April 2022, the observed rate of encounters matched the expected rate that accounted for this trend. During the full pandemic period, from March 2020 to June 2023, there were an estimated 5% (95% prediction interval, 1%-9%) fewer AMI hospital encounters than expected.
The early reduction in AMI encounters was likely driven by care avoidance, while ongoing reductions through June 2023 likely reflect long-standing temporal trends. During the pandemic, there were 5% fewer AMI encounters than expected.
在新冠疫情早期,急性心肌梗死(AMI)住院病例数急剧下降,且尚未恢复到疫情前水平。关于导致这种下降的潜在机制一直存在争论,包括患者避免就医、原本会发生AMI的患者因新冠死亡、与疫情相关的行为变化导致AMI发病率或严重程度降低,或者AMI发病率存在先前的下降趋势。
描述新冠疫情期间AMI住院病例数变化的驱动因素。
设计、设置和参与者:这项横断面研究使用了2016年1月至2023年6月所有参加传统医疗保险患者的传统医疗保险理赔数据(总计28.5亿患者月),以计算美国所有短期急性护理医院和临界接入医院总体及按患者特征划分的人均AMI住院病例数(急诊就诊、观察住院或住院治疗)。将观察到的发病率与考虑了人口特征变化和疫情前时间趋势(根据2016 - 2019年估算)的预期发病率进行比较。数据于2023年11月进行分析。
AMI住院病例数。
从2016年1月到2023年6月,研究样本平均每月包括31623928名患者,在90个月的研究期间总计2846153487患者月。2023年6月,每100名患者中有0.044例AMI住院病例,比2019年6月(每100名患者中有0.055例)低20%。在疫情早期,AMI发病率与新冠死亡率呈反向变化,并跟踪了其他疼痛性急性疾病(如肾结石)的模式,表明这些变化与避免就医有关。疫情期间因超额死亡导致的患者特征变化对下降的解释作用很小。在疫情后期,下降可能由AMI发病率长期下降趋势来解释;到2022年4月,观察到的病例数与考虑该趋势后的预期发病率相符。在整个疫情期间,从2020年3月到2023年6月,估计AMI住院病例数比预期少5%(95%预测区间为1% - 9%)。
AMI病例数早期减少可能是由于避免就医,而到2023年6月持续减少可能反映了长期的时间趋势。在疫情期间,AMI病例数比预期少5%。